Common variants in KCNN3 are associated with lone atrial fibrillation

Nature Genetics

Volumn 42, Issue 3, 2010, Pages 240-244

  Ellinor, Patrick T ^a   Lunetta, Kathryn L ^b,c   Glazer, Nicole L ^d   Pfeufer, Arne ^e,f   Alonso, Alvaro ^g   Chung, Mina K ^h   Sinner, Moritz F ⁱ   De Bakker, Paul I W ^j,k   Mueller, Martina ^f,i,l   Lubitz, Steven A ^a,j   Fox, Ervin ^m   Darbar, Dawood ⁿ   Smith, Nicholas L ^o,p   Smith, Jonathan D ^h   Schnabel, Renate B ^c   Soliman, Elsayed Z ^q   Rice, Kenneth M ^o   Van Wagoner, David R ^h   Beckmann, Britt M ⁱ   Van Noord, Charlotte ^r,s,t   Wang, Ke ^b   Ehret, Georg B ^u,am   Rotter, Jerome I ^v   Hazen, Stanley L ^h   Steinbeck, Gerhard ⁱ   Smith, Albert V ^w,x   Launer, Lenore J ^y   Harris, Tamara B ^y   Makino, Seiko ^a   Nelis, Mari ^z,aa   Milan, David J ^a   Perz, Siegfried ^f   Esko, Tnu ^z,aa   Köttgen, Anna ^ab   Moebus, Susanne ^ac   Newton Cheh, Christopher ^a,k   Li, Man ^ab   Möhlenkamp, Stefan ^ad   Wang, Thomas J ^a,c   Linda Kao, W H ^ab   Vasan, Ramachandran S ^c,ae   Nöthen, Markus M ^z,af   MacRae, Calum A ^j   Ch Stricker, Bruno H ^r,t,ag   Hofman, Albert ^r,t   Uitterlinden, André G ^r,t   Levy, Daniel ^ah   Boerwinkle, Eric ^ai,aj   Metspalu, Andres ^z,aa   Topol, Eric J ^ak   Chakravarti, Aravinda ^u   Gudnason, Vilmundur ^w,x   Psaty, Bruce M ^d,al   Roden, Dan M ⁿ   Meitinger, Thomas ^e,f   Wichmann, H Erich ^f,i,l   Witteman, Jacqueline C M ^r,t   Barnard, John ^h   Arking, Dan E ^u   Benjamin, Emelia J ^b,c,ae   Heckbert, Susan R ^o,al   Kääb, Stefan ^i,af   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON UNIVERSITY   (United States)

^c FRAMINGHAM HEART STUDY   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f INSTITUTE OF EPIDEMIOLOGY   (Germany)

^g UNIVERSITY OF MINNESOTA   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^l UNIVERSITY OF MUNICH   (Germany)

^m UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

ⁿ VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF WASHINGTON   (United States)

^p DEPARTMENT OF VETERANS AFFAIRS   (United States)

^q WAKE FOREST SCHOOL OF MEDICINE   (United States)

^r ERASMUS MEDICAL CENTER   (Netherlands)

^s MEDICINES EVALUATION BOARD   (Netherlands)

^t Netherlands Consortium for Healthy Ageing   (Netherlands)

^u JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^v CEDARS SINAI MEDICAL CENTER   (United States)

^w ICELANDIC HEART ASSOCIATION   (Iceland)

^x UNIVERSITY OF ICELAND   (Iceland)

^y NATIONAL INSTITUTE ON AGING   (United States)

^z UNIVERSITY OF TARTU   (Estonia)

^aa UNIVERSITY OF TARTU   (Estonia)

^ab JOHNS HOPKINS UNIVERSITY   (United States)

^ac UNIVERSITY OF DUISBURG ESSEN   (Germany)

^ad UNIVERSITY HOSPITAL ESSEN   (Germany)

^ae BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^af UNIVERSITY OF BONN   (Germany)

^ag Inspectorate for Health Care   (Netherlands)

^ah NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^ai UNIVERSITY OF TEXAS   (United States)

^aj UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^ak SCRIPPS RESEARCH INSTITUTE   (United States)

^al GROUP HEALTH RESEARCH INSTITUTE   (United States)

^am GENEVA UNIVERSITY HOSPITALS   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM ACTIVATED POTASSIUM CHANNEL KCNN3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHROMOSOME 1Q; CHROMOSOME 20Q; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GENOME ANALYSIS; HEART ATRIUM FIBRILLATION; HEART REPOLARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTRONS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; YOUNG ADULT;

EID: 77649191092     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.537     Document Type: Article

References (32)

1. Fuster, V. et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114, e257-e354 (2006).
2. Jahangir, A. et al. Long-term progression and outcomes with aging in patients with lone atrial fbrillation: a 30-year follow-up study. Circulation 115, 3050-3056 (2007).
3. Ellinor, P.T., Yoerger, D.M., Ruskin, J.N. & MacRae, C.A. Familial aggregation in lone atrial fbrillation. Hum. Genet. 118, 179-184 (2005).
4. Fox, C.S. et al. Parental atrial fbrillation as a risk factor for atrial fbrillation in offspring. J. Am. Med. Assoc. 291, 2851-2855 (2004).
5. Arnar, D.O. et al. Familial aggregation of atrial fbrillation in Iceland. Eur. Heart J. 27, 708-712 (2006).
6. Gudbjartsson, D.F. et al. Variants conferring risk of atrial fbrillation on chromosome 4q25. Nature 448, 353-357 (2007).
7. Benjamin, E.J. et al. Variants in ZFHX3 are associated with atrial fbrillation in individuals of European ancestry. Nat. Genet. 41, 879-881 (2009).
8. Gudbjartsson, D.F. et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fbrillation and ischemic stroke. Nat. Genet. 41, 876-878 (2009).
9. Kozlowski, D. et al. Lone atrial fbrillation-what do we know? Heart published online, doi:10.1136/hrt.2009.176321 (26 August 2009). K, M. et al. Small-conductance, calcium-activated potassium channels from mammalian brain. Science 273, 1709-1714 (1996).
10. Xu, Y. et al. Molecular identifcation and functional roles of a Ca2+-activated K+ channel in human and mouse hearts. J. Biol. Chem. 278, 49085-49094 (2003).
11. Tuteja, D. et al. Differential expression of small-conductance Ca2+-activated K+ channels SK1, SK2, and SK3 in mouse atrial and ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 289, H2714-H2723 (2005).
12. Ozgen, N. et al. Early electrical remodeling in rabbit pulmonary vein results from traffcking of intracellular SK2 channels to membrane sites. Cardiovasc. Res. 75, 758-769 (2007).
13. Nattel, S. New ideas about atrial fbrillation 50 years on. Nature 415, 219-226 (2002).
14. Zhang, Q. et al. Functional roles of a Ca2+-activated K+ channel in atrioventricular nodes. Circ. Res. 102, 465-471 (2008).
15. Monaghan, A.S. et al. The SK3 subunit of small conductance Ca2+-activated K+ channels interacts with both SK1 and SK2 subunits in a heterologous expression system. J. Biol. Chem. 279, 1003-1009 (2004).
16. Taylor, M.S. et al. Altered expression of small-conductance Ca2+-activated K+ (SK3) channels modulates arterial tone and blood pressure. Circ. Res. 93, 124-131 (2003).
17. International HapMap Consortium. The International HapMap Project. Nature 426, 789-796 (2003).
18. Newton-Cheh, C. et al. Genome-wide association study identifes eight loci associated with blood pressure. Nat. Genet. 41, 666-676 (2009).
19. Johnson, A.D. et al. SNAP: a web-based tool for identifcation and annotation of proxy SNPs using HapMap. Bioinformatics 24, 2938-2939 (2008).
20. Kaab, S. et al. Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fbrillation. Eur. Heart J. 30, 813-819 (2009).
21. Wichmann, H.E., Gieger, C. & Illig, T. KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 67 (Suppl. 1), S26-S30 (2005).
22. Dawber, T.R., Meadors, G.F. & Moore, F.E. Jr. Epidemiological approaches to heart disease: the Framingham Study. Am. J. Public Health Nations Health 41, 279-281 (1951).
23. Kannel, W.B., Feinleib, M., McNamara, P.M., Garrison, R.J. & Castelli, W.P. An investigation of coronary heart disease in families. The Framingham offspring study. Am. J. Epidemiol. 110, 281-290 (1979).
24. Splansky, G.L. et al. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am. J. Epidemiol. 165, 1328-1335 (2007).
25. Heckbert, S.R., Li, G., Cummings, S.R., Smith, N.L. & Psaty, B.M. Use of alendronate and risk of incident atrial fbrillation in women. Arch. Intern. Med. 168, 826-831 (2008).
26. Fried, L.P. et al. The Cardiovascular Health Study: design and rationale. Ann. Epidemiol. 1, 263-276 (1991)
27. Anonymous. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am. J. Epidemiol. 129, 687-702 (1989).
28. Darbar, D., Motsinger, A.A., Ritchie, M.D., Gainer, J.V. & Roden, D.M. Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fbrillation. Heart Rhythm 4, 743-749 (2007).
29. Servin, B. & Stephens, M. Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet. 3, e114 (2007).
30. Price, A.L. et al. Principal components analysis corrects for stratifcation in genome-wide association studies. Nat. Genet. 38, 904-909 (2006).
31. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007).
32. de Bakker, P.I. et al. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum. Mol. Genet. 17, R122-R128 (2008).